[go: up one dir, main page]

ZA931222B - TNF inhibitors - Google Patents

TNF inhibitors

Info

Publication number
ZA931222B
ZA931222B ZA931222A ZA931222A ZA931222B ZA 931222 B ZA931222 B ZA 931222B ZA 931222 A ZA931222 A ZA 931222A ZA 931222 A ZA931222 A ZA 931222A ZA 931222 B ZA931222 B ZA 931222B
Authority
ZA
South Africa
Prior art keywords
tnf inhibitors
tnf
inhibitors
Prior art date
Application number
ZA931222A
Inventor
Klaus Max Esser
Peter Lawrence Demarsh
Carrie Lynn Drey
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA931222B publication Critical patent/ZA931222B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA931222A 1992-02-21 1993-02-22 TNF inhibitors ZA931222B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83983892A 1992-02-21 1992-02-21

Publications (1)

Publication Number Publication Date
ZA931222B true ZA931222B (en) 1993-11-29

Family

ID=25280753

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931222A ZA931222B (en) 1992-02-21 1993-02-22 TNF inhibitors

Country Status (4)

Country Link
AU (1) AU3725893A (en)
MX (1) MX9300959A (en)
WO (1) WO1993016699A1 (en)
ZA (1) ZA931222B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6930101B1 (en) 1999-05-17 2005-08-16 The Regents Of The University Of California Thiazolopyrimidines useful as TNFα inhibitors
KR101100601B1 (en) * 2004-02-14 2011-12-29 글락소스미스클라인 엘엘씨 New compounds
EP1912991B1 (en) 2005-08-10 2010-11-10 GlaxoSmithKline LLC Xanthine derivatives as selective hm74a agonists
CN107206002B (en) * 2015-01-30 2019-07-16 上海珊顿医药科技有限公司 Prevention or treatment of uric acid or gouty diseases
WO2023187607A1 (en) 2022-03-29 2023-10-05 Universidade Nova De Lisboa Nickel n-heterocyclic carbene complexes based on xanthines and use therof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8906792D0 (en) * 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds

Also Published As

Publication number Publication date
MX9300959A (en) 1994-08-31
AU3725893A (en) 1993-09-13
WO1993016699A1 (en) 1993-09-02

Similar Documents

Publication Publication Date Title
GB9116684D0 (en) Corrosion inhibitors
SG46381A1 (en) Leukoriene biiosynthese inhibitor
IL108075A0 (en) Enzyme inhibitors
AU8292091A (en) Tnf inhibitors
HU9400952D0 (en) Heteroaryl-amines as acetyl-cholinesterase inhibitors
AU648907B2 (en) Corrosion inhibitors
GB9307266D0 (en) Pipe
HU9301509D0 (en) Tnf inhibitors
CA72592S (en) Block
GB9214720D0 (en) Enzyme inhibitors
ZA931222B (en) TNF inhibitors
GB9203145D0 (en) Brickwork
GB2282826B (en) Hard facing
GB9217116D0 (en) Methods
GB9201804D0 (en) Methods
GB9201803D0 (en) Methods
EP0543936A4 (en) Renin inhibitors
ZA916059B (en) Tnf inhibitors
HU9904088D0 (en) Dual action inhibitors
GB9205147D0 (en) Line full device-cask
GB9319252D0 (en) Pathway inhibitors
GB9118480D0 (en) Steroid suphatase inhibitors
GB9026251D0 (en) Netalloproteinase inhibitors
NO920441D0 (en) TNF inhibitor
ZA938867B (en) Enzyme inhibitors